HR 4710
116th Congress
House
Armed Forces and National Security
Buy American requirements
Congressional oversight
Drug safety, medical device, and laboratory regulation
Health technology, devices, supplies
Immunology and vaccination
Industrial policy and productivity
Manufacturing
Military medicine
Military operations and strategy
Military procurement, research, weapons development
Military readiness
Prescription drugs
Public contracts and procurement
Strategic materials and reserves
Veterans' medical care
Pharmaceutical Independence Long-Term Readiness Reform Act
Introduced: October 17, 2019
Introduced by:
Garamendi, John
Democratic
· California
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 8, 2019
Referred to the Subcommittee on Health.
Oct 17, 2019
Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 17, 2019
Sponsor introductory remarks on measure. (CR E1297-1298)
Oct 17, 2019
Introduced in House
Plain-English summary
Pharmaceutical Independence Long-Term Readiness Reform Act
This bill generally requires the Department of Defense (DOD) and the Department of Veterans Affairs to only purchase American-made medicines and vaccines. DOD must also (1) report to Congress on medicine supply-chain vulnerabilities, and (2) establish strategies to assure the provision of medicines to enable combat readiness and force health protection.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4